These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32239695)

  • 1. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group.
    Au-Yeung RKH; Arias Padilla L; Zimmermann M; Oschlies I; Siebert R; Woessmann W; Burkhardt B; Klapper W
    Br J Haematol; 2020 Sep; 190(5):753-763. PubMed ID: 32239695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
    Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
    J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas.
    Horn H; Kalmbach S; Wagener R; Staiger AM; Hüttl K; Mottok A; Bens S; Traverse-Glehen A; Fontaine J; Siebert R; Rosenwald A; Ott G
    Am J Surg Pathol; 2021 Mar; 45(3):356-364. PubMed ID: 33136583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
    Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.
    Gonzalez-Farre B; Ramis-Zaldivar JE; Salmeron-Villalobos J; Balagué O; Celis V; Verdu-Amoros J; Nadeu F; Sábado C; Ferrández A; Garrido M; García-Bragado F; de la Maya MD; Vagace JM; Panizo CM; Astigarraga I; Andrés M; Jaffe ES; Campo E; Salaverria I
    Haematologica; 2019 Sep; 104(9):1822-1829. PubMed ID: 30733272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.
    Rymkiewicz G; Grygalewicz B; Chechlinska M; Blachnio K; Bystydzienski Z; Romejko-Jarosinska J; Woroniecka R; Zajdel M; Domanska-Czyz K; Martin-Garcia D; Nadeu F; Swoboda P; Rygier J; Pienkowska-Grela B; Siwicki JK; Prochorec-Sobieszek M; Salaverria I; Siebert R; Walewski J
    Mod Pathol; 2018 May; 31(5):732-743. PubMed ID: 29327714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological and molecular genetic features of Burkitt-like lymphoma with 11q aberration].
    Zhang YP; Zhang L; Zhang DD; Wang GN; Zhao WG; Jian XY; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):604-608. PubMed ID: 34078047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fluorescence in situ hybridization in the diagnosis of aggressive B-cell lymphomas].
    Gerhard-Hartmann E; Rosenwald A
    Pathologe; 2020 Nov; 41(6):574-581. PubMed ID: 32909092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.
    Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Borkowska K; Kotyl A; Blachnio K; Bystydzienski Z; Nowakowska B; Pienkowska-Grela B
    Am J Clin Pathol; 2017 Dec; 149(1):17-28. PubMed ID: 29272887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma.
    Gebauer N; Witte HM; Merz H; Oschlies I; Klapper W; Caliebe A; Tharun L; Spielmann M; von Bubnoff N; Feller AC; Murga Penas EM
    Blood Adv; 2021 Dec; 5(23):5220-5225. PubMed ID: 34500469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification.
    Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Malawska N; Blachnio K; Bystydzienski Z; Borysiuk A; Nowakowska B; Pienkowska-Grela B
    Cancer Genet; 2020 Jul; 245():1-5. PubMed ID: 32531723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases.
    Shestakova A; Shao L; Smith LB; Ryan R; Bedell V; Murata-Collins J; Zhang W; Perry AM; Song JY
    Hum Pathol; 2023 Jun; 136():34-43. PubMed ID: 36997031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
    Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
    Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and differential diagnosis of large B-cell lymphoma with IRF4 rearrangement].
    Luo D; Xiang CX; Ma DS; Liu GZ; Fan MT; Wang YB; Zhao J; Yuan YQ; Shen QQ; Liu XY; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):563-569. PubMed ID: 38825901
    [No Abstract]   [Full Text] [Related]  

  • 17. Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
    Seegmiller AC; Garcia R; Huang R; Maleki A; Karandikar NJ; Chen W
    Mod Pathol; 2010 Jul; 23(7):909-20. PubMed ID: 20348878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
    Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Rodriguez-Pinilla SM; Dojcinov S; Dotlic S; Gibson SE; Hartmann S; Klimkowska M; Sabattini E; Tousseyn TA; de Jong D; Hsi ED
    Virchows Arch; 2024 Jan; 484(1):15-29. PubMed ID: 37530792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment for 11q and other chromosomal aberrations in large B-cell/high-grade B cell lymphomas of germinal center phenotype lacking BCL2 expression.
    Ho CC; Naresh K; Liu Y; Wu Y; Gopal AK; Eckel AM
    Cancer Genet; 2024 Jun; 284-285():30-33. PubMed ID: 38520765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.